Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest National Osteoporosis Foundation Stories

2014-01-15 16:23:21

BINOSTO® offers a liquid alternative to the 74 percent of patients who want a treatment choice. SAN ANTONIO, Jan. 15, 2014 /PRNewswire/ -- Most osteoporosis patients want a choice in the medication they take, according to a recent online survey* sponsored by Mission Pharmacal Company. The survey, conducted by Inspire among the National Osteoporosis Foundation online support community, revealed that 74 percent of osteoporosis patients surveyed prefer to take medication that comes in...

2013-12-30 16:21:21

Fracture Liaison Service Programs are the Solution to Reducing the Two Million Bone Breaks Caused by Osteoporosis Each Year. WASHINGTON, Dec. 30, 2013 /PRNewswire-USNewswire/ -- The National Osteoporosis Foundation (NOF) today announced a comprehensive Fracture Prevention Initiative in partnership with the National Bone Health Alliance (NBHA). Their goal is to provide a broad-based, best-practice model-of-care to reduce the nearly 80 percent post-fracture care gap. (Logo:...

2013-12-05 08:30:41

CECity, NBHA and NOF Launch Study funded by Merck and Co. to Assess Hospital Use of Proven Fracture Liaison Service Model Across Communities Utilizing Cloud-Based MedConcert® Platform PITTSBURGH, Dec. 5, 2013 /PRNewswire/ -- Despite 15 years of documented international success of the Fracture Liaison Service (FLS) model of post-fracture care to identify patients at risk in order to prevent costly and deadly secondary fractures in patients with osteoporosis, relatively few hospitals...

2013-10-04 08:23:39

Prolia Open-Label Extension Trial Showed Continued Increases in Bone Mineral Density and Low Fracture Incidence for Up to Eight Years THOUSAND OAKS, Calif., Oct. 4, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will present data from several romosozumab and Prolia(®) (denosumab) studies at the American Society for Bone and Mineral Research (ASBMR) 2013 Annual Meeting in Baltimore from Oct. 4-7, 2013. Romosozumab data include results from the Phase 2 study that demonstrate...

2013-09-26 08:28:16

Emmy-Award Winning Journalist Juju Chang to Emcee Event Honoring Champions for Bone Health WASHINGTON, Sept. 26, 2013 /PRNewswire-USNewswire/ -- The National Osteoporosis Foundation (NOF), the nation's leading health organization dedicated to preventing osteoporosis and broken bones, will celebrate Generations of Strength at its annual fundraising luncheon on Monday, September 30, 2013. The event honors two outstanding bone health champions and will take place from 11:30 a.m. to 1:30...

2013-05-01 20:22:20

The National Osteoporosis Foundation Launches New Campaign for National Osteoporosis Month WASHINGTON, May 1, 2013 /PRNewswire-USNewswire/ -- In response to new prevalence data showing approximately 57 million Americans are affected by osteoporosis and low bone mass, the National Osteoporosis Foundation (NOF) kicked off a new national awareness campaign today, celebrating May as National Osteoporosis Month. Break Free from Osteoporosis encourages the public to get to know their risk...

2013-04-18 08:30:41

With Nearly 57 Million Adults Age 50 and Older Affected by Osteoporosis and Low Bone Mass, NOF Announces the Break Free from Osteoporosis Campaign WASHINGTON, April 18, 2013 /PRNewswire-USNewswire/ -- The National Osteoporosis Foundation (NOF) today released new prevalence data estimating that approximately 9 million adults in the U.S. have osteoporosis and more than 48 million have low bone mass (indicated by T-scores between -1.0 and -2.5), placing them at increased risk for...

2013-02-26 16:26:39

Despite Recent Studies, Calcium and Vitamin D Remain Important Nutrients for Overall Bone Health WASHINGTON, Feb. 26, 2013 /PRNewswire-USNewswire/ -- In response to the U.S. Preventive Services Task Force's (USPSTF) recommendation stating that there is insufficient evidence to assess the balance of benefits and harms of calcium and vitamin D supplementation for the primary prevention of fractures, the National Osteoporosis Foundation (NOF) reminds the public that both nutrients are an...

2012-09-20 14:24:00

THOUSAND OAKS, Calif., Sept. 20, 2012 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the U.S. Food and Drug Administration (FDA) approved a new indication for Prolia(®) (denosumab) as a treatment to increase bone mass in men with osteoporosis at high risk for fracture. Prolia, the first FDA-approved RANK Ligand inhibitor, is a subcutaneous injection administered by a health care professional every six months. "While osteoporosis and osteoporosis-related fractures are more commonly...

2012-06-15 06:24:09

TORONTO, June 15, 2012 /CNW/ - Join Osteoporosis Canada (OC) on June 17, 2012 as it celebrates 30 years of dedicated service to those with or at risk of osteoporosis.  Established in 1982, the first organization in the world committed solely to bone health. Osteoporosis Canada remains the only organization in Canada with this primary focus. Through its 22 chapters and network of health care professionals, OC disseminates information on building and maintaining bone health...


Latest National Osteoporosis Foundation Reference Libraries

Osteoporosis International
2012-05-17 15:25:40

Osteoporosis International is a peer-reviewed medical journal published monthly by Springer Science+Business Media. It was established in 1990. It is the official journal of the International Osteoporosis Foundation and the National Osteoporosis Foundation. The journal includes original research on all areas of osteoporosis and related fields. It also publishes reviews, educational articles, and case reports. Editors-in-chief are R. Lindsay and J.A. Kanis. According to the Journal...

More Articles (1 articles) »